FR2609395B1 - Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee - Google Patents

Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee

Info

Publication number
FR2609395B1
FR2609395B1 FR8802163A FR8802163A FR2609395B1 FR 2609395 B1 FR2609395 B1 FR 2609395B1 FR 8802163 A FR8802163 A FR 8802163A FR 8802163 A FR8802163 A FR 8802163A FR 2609395 B1 FR2609395 B1 FR 2609395B1
Authority
FR
France
Prior art keywords
composition
pharmaceutical
cosmetic
prepared
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8802163A
Other languages
English (en)
Other versions
FR2609395A1 (fr
Inventor
Marc Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Laboratoires Serobiologiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serobiologiques SA filed Critical Laboratoires Serobiologiques SA
Priority to FR8802163A priority Critical patent/FR2609395B1/fr
Publication of FR2609395A1 publication Critical patent/FR2609395A1/fr
Application granted granted Critical
Publication of FR2609395B1 publication Critical patent/FR2609395B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR8802163A 1988-02-23 1988-02-23 Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee Expired - Lifetime FR2609395B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8802163A FR2609395B1 (fr) 1988-02-23 1988-02-23 Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802163A FR2609395B1 (fr) 1988-02-23 1988-02-23 Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee

Publications (2)

Publication Number Publication Date
FR2609395A1 FR2609395A1 (fr) 1988-07-15
FR2609395B1 true FR2609395B1 (fr) 1992-01-10

Family

ID=9363521

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8802163A Expired - Lifetime FR2609395B1 (fr) 1988-02-23 1988-02-23 Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee

Country Status (1)

Country Link
FR (1) FR2609395B1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675967A5 (fr) * 1987-12-09 1990-11-30 Induchem Ag
US5028428A (en) * 1988-08-09 1991-07-02 Estee Lauder Inc. Anti-irritant and desensitizing compositions and methods of their use
FR2649610B1 (fr) * 1989-07-13 1994-06-03 Dior Christian Parfums Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
GB8926595D0 (en) * 1989-11-24 1990-01-17 Surtech Int Ltd Pharmaceutical compositions for use in the treatment herpes simplex virus infections
FR2654935B1 (fr) * 1989-11-28 1994-07-01 Lvmh Rech Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux.
AU5098396A (en) * 1995-04-07 1996-10-23 Kuyus-Stiftung Cosmetic composition for treating cellulite
DE19606545A1 (de) * 1996-02-22 1997-08-28 Wella Ag Kosmetisches Mittel mit einem Gehalt an Ilexharz, Verfahren zur Gewinnung von Ilexharz und durch dieses Verfahren erhältliches Ilexharz
FR2812873B1 (fr) 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
WO2004103334A1 (fr) * 2003-05-20 2004-12-02 Sederma Composition cosmetique amincissante contenant du cafestol et du kahweoel
FR2855057B1 (fr) * 2003-05-20 2006-07-14 Sederma Sa Composition cosmetique ou dermopharmaceutique amincissante
EP1753387B1 (fr) * 2004-04-08 2012-05-23 VDF Futureceuticals, Inc. Procedes et compositions cosmetiques a base du fruit du cafeier
FR2879924B1 (fr) * 2004-12-23 2007-06-15 Soc Extraction Principes Actif Composition cosmetique amincissante
FR2879925B1 (fr) * 2004-12-23 2007-06-15 Soc Extraction Principes Actif Composition cosmetique amincissante
DE102005021805B3 (de) * 2005-05-04 2006-10-05 Lancaster Group Gmbh Kosmetisches Verfahren zur Körpermodellierung mit Sonnenschutz und Modellierungs-Set
GB0801119D0 (en) 2008-01-22 2008-02-27 Barry Callebaut Ag Composition
FR2942721B1 (fr) * 2009-03-09 2013-02-01 Peaux Cibles Procede de traitement cosmetique et pharmaceutique destine a reduire a la fois les rides et augmenter la fermete sans provoquer de lipolyse et compositions pour sa mise en oeuvre
FR2999080B1 (fr) 2012-12-11 2015-03-20 Isp Investments Inc Utilisation cosmetique de l'association d'un extrait de de germe de caroube et de cafeine en tant qu'agent actif amincissant
FR2999079B1 (fr) 2012-12-11 2015-04-24 Isp Investments Inc Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant
EP3509706B1 (fr) 2016-09-07 2021-11-03 ISP Investments LLC Procédé permettant d'augmenter la lipolyse à l'aide d'une composition comprenant un extrait bioactif de nelumbo nucifera (lotus)

Also Published As

Publication number Publication date
FR2609395A1 (fr) 1988-07-15

Similar Documents

Publication Publication Date Title
FR2609395B1 (fr) Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee
FR2627385B3 (fr) Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
IT1251741B (it) Composizioni farmaceutiche e cosmetiche depigmentanti a base di acido caffeico.
IT8522009A0 (it) Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
CA2033725A1 (fr) Compositions pharmaceutiques et cosmetiques
ES2036039T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.
FR2597345B1 (fr) Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
ES2013639B3 (es) Nuevas composiciones tensioactivas a base de esteres fosforicos, su procedimiento de preparacion y su aplicacion a la formulacion de materias activas.
IT8519873A0 (it) Procedimento di solubilizzazione di principi attivi e composizioni farmaceutiche cosi' ottenute.
FR2609397B1 (fr) Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique
FR2639828B1 (fr) Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
FR2628973B1 (fr) Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
CA2025855A1 (fr) Composes pharmaceutiques ayant une action sur la microcirculation cutanee
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
FR2619505B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
IE872239L (en) Pyridopyrimidinediones and quinazolines
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
CA2075926A1 (fr) Esters d'acides amines et d'hydroquinone, methodes d'obtention et compositions phramaceutiques ou cosmetiques qui en contiennent
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
FR2649610B1 (fr) Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
FR2651679B1 (fr) Application d'hydrolysats de globines pour la stimulation cellulaire et produits pharmaceutiques et cosmetiques obtenus.
AU625769B2 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis- inhibiting endermic preparation containing the same compound as active ingredient

Legal Events

Date Code Title Description
ST Notification of lapse